Search - Prime Therapeutics
388 Results for GLP-1 Pipeline Update
-
Expert Clinical Network Insights Hemophilia December 17, 2024 Medication insights: marstacimab-hncq (Hympavzi) The U.S. Food and Drug Administration (FDA) approved marstacimab-hncq (Hympavzi) in...
-
publications Drug Approvals: February 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches February 28, 2025 Specialty New drugs...
-
Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024
Prime Article: Stories -
In this episode, our experts discuss Prime’s four primary tenets of practice for chronic weight management.
Prime Article: Stories
Compliance / Legal
© 2025 Prime Therapeutics LLC